Bush Administration Asks for Authority to Approve Generic Biologics; U.K. to Require Earlier Release of Adverse Trial Data; FDA Plans More Communication on Drug Risks; FDA Sets Out Rules for Distribution of Papers on Unapproved Uses; Grassley Asks GAO to Probe FDA Approvals; Supreme Court Splits on Rezulin Question; Medical Device Amendments Shield Manufacturers; PDUFA Deadlines Associated with More Approvals of Drugs Found to Have Safety Problems; Bill Barring Genetic Discrimination Passes House; FDA Rejects Advisory Committee Advice, Approves Avastin for Advanced Breast Cancer; Class Certification for Medical Monitoring Denied; Mandated Release of Scientific, Medical Papers Delayed